JPRN-UMIN000001594
Unknown
Phase 1
Phase I trial to assess safety and pharmacokinetics of Gefitinib plus S-1 combination therapy in patients with advanced adenocarcinoma lung - Phase I trial of Gefitinib plus S-1 combination therapy for advanced adenocarcinoma of the lung
Kinki University School of Medicine0 sites20 target enrollmentDecember 22, 2008
Conditionsung Cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- ung Cancer
- Sponsor
- Kinki University School of Medicine
- Enrollment
- 20
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II trial for safety and pharmacokinetics of ENDOPIN in healthy adults and patients with paiPhase 1 part: Healthy adult male Phase 2 part: Postoperative pain patientspostoperative painD010149JPRN-jRCT2051220144akajima Takako46
Recruiting
Phase 1
PedMAb1HIV/AIDSPACTR202205715278722South African Medical Research Council72
Completed
Not Applicable
Phase 1 study to evaluate safety and pharmacokinetic property of DNP001 in patients with JL1 postive acute leukemia or myelodysplastic syndromeKCT0002421Asan Medical Center18
Active, not recruiting
Phase 1
Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-511259-16-00Repare Therapeutics USA Inc.80
Completed
Phase 1
Safety, efficacy and pharmacokinetic study of paclitaxel injection concentrate for nano-dispersion in subjects with metastatic breast cancer.CTRI/2009/091/000262Sun Pharma Advanced Research Company Ltd36